Niddk: supply: purchase of microplate plate reader for enzymatic characterization of epigenetic regulations of o-glcnac cycling enzymes

Ended Awarded Last action

Contract number
75N94025F00091
Awardee
Awarding agency
Obligated
$47,757

Award facts

Opportunity
  • RFQ1773207 Solicitation number
Contract value 100% obligated
$47,756.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
Total Small Business
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cary, NC 27513, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $47,757 delivery order to BMG Labtech, Inc., a small business headquartered in Cary, North Carolina, for the purchase of a microplate plate reader. The equipment will support enzymatic characterization research focusing on epigenetic regulations of O-GlcNAc cycling enzymes. This Total Small Business set-aside contract is structured as a firm fixed price delivery order under the General Services Administration's Multiple Award Schedule (MAS), with performance scheduled for completion by November 19, 2025. The work will be performed at the contractor's location in Cary, NC.

BMG Labtech specializes in the manufacture and supply of advanced laboratory instrumentation, particularly microplate readers and related scientific equipment used in biomedical research. The company maintains an active MAS contract with the federal government and has a long history of providing specialized laboratory equipment to civilian agencies within the Department of Health and Human Services, including various National Institutes of Health divisions. This procurement supports NIDDK's research mission in metabolic and kidney diseases by enabling critical analytical capabilities for understanding post-translational protein modifications relevant to diabetes and related conditions.

Quick answers

Who was awarded contract 75N94025F00091?

75N94025F00091 was awarded to BMG Labtech, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on September 19, 2025.

How much is contract 75N94025F00091 worth?

The government has obligated $47,757 on 75N94025F00091.

Which agency awarded contract 75N94025F00091?

National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025F00091, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).

Is contract 75N94025F00091 an order under another contract?

Yes. 75N94025F00091 is a delivery order under GS07F057DA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75N94025F00091 competed?

The extent of competition for 75N94025F00091 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award